ARTRYA Ltd (AYA) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.122x

Based on the latest financial reports, ARTRYA Ltd (AYA) has a cash flow conversion efficiency ratio of -0.122x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-10.88 Million ≈ $-7.70 Million USD) by net assets (AU$89.35 Million ≈ $63.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check AYA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

ARTRYA Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how ARTRYA Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See ARTRYA Ltd shareholders equity for net asset value and shareholders' equity analysis.

ARTRYA Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ARTRYA Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Longjian Road & Bridge Co Ltd
SHG:600853
0.111x
Peet Ltd
AU:PPC
0.104x
RattanIndia Enterprises Limited
NSE:RTNINDIA
0.010x
Tecnon Fujian Commercial Lighting Co Ltd
SHE:300650
-0.166x
Zhejiang Netsun Co Ltd
SHE:002095
0.015x
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
N/A
Richtech Robotics Inc. Class B Common Stock
NASDAQ:RR
-0.005x
Infund Holding Co Ltd
SHE:002141
0.075x

Annual Cash Flow Conversion Efficiency for ARTRYA Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of ARTRYA Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see ARTRYA Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$21.29 Million
≈ $15.06 Million
AU$-14.27 Million
≈ $-10.10 Million
-0.670x +26.89%
2024-06-30 AU$16.80 Million
≈ $11.89 Million
AU$-15.41 Million
≈ $-10.90 Million
-0.917x -160.90%
2023-06-30 AU$30.56 Million
≈ $21.62 Million
AU$-10.74 Million
≈ $-7.60 Million
-0.351x -48.68%
2022-06-30 AU$40.64 Million
≈ $28.76 Million
AU$-9.61 Million
≈ $-6.80 Million
-0.236x -711.62%
2021-06-30 AU$51.05 Million
≈ $36.12 Million
AU$-1.49 Million
≈ $-1.05 Million
-0.029x +95.53%
2020-06-30 AU$2.49 Million
≈ $1.76 Million
AU$-1.62 Million
≈ $-1.15 Million
-0.651x -478.82%
2019-06-30 AU$852.97K
≈ $603.53K
AU$-95.94K
≈ $-67.89K
-0.112x --

About ARTRYA Ltd

AU:AYA Australia Health Information Services
Market Cap
$528.23 Million
AU$746.55 Million AUD
Market Cap Rank
#12278 Global
#315 in Australia
Share Price
AU$4.66
Change (1 day)
+0.22%
52-Week Range
AU$0.61 - AU$5.07
All Time High
AU$5.07
About

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more